The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Patient Income Level and Cancer Clinical Trial Participation
Open accessAbstract
Purpose: Studies have shown an association between socioeconomic status (SES) and quality of oncology care, but less is known about the impact of patient SES on clinical trial participation. Patients and Methods: We assessed clinical trial participation patterns according to important SES (income, education) and demographic factors in a large sample of patients surveyed via an Internet-based treatment decision tool. Logistic regression, conditioning on type of cancer, was used. Attitudes toward clinical trials were assessed using prespecified items about treatment, treatment tolerability, convenience, and cost. Results: From 2007 to 2011, 5,499 patients were successfully surveyed. Forty percent discussed clinical trials with their physician, 45% of discussions led to physician offers of clinical trial participation, and 51% of offers led to clinical trial participation. The overall clinical trial participation rate was 9%. In univariate models, older patients (P = .002) and patients with lower income (P = .001) and education (P = .02) were less likely to participate in clinical trials. In a multivariable model, income remained a statistically significant predictor of clinical trial participation (odds ratio, 0.73; 95% CI, 0.57 to 0.94; P = .01). Even in patients age ≥ 65 years, who have universal access to Medicare, lower income predicted lower trial participation. Cost concerns were much more evident among lower-income patients (P < .001). Conclusion: Lower-income patients were less likely to participate in clinical trials, even when considering age group. A better understanding of why income is a barrier may help identify ways to make clinical trials better available to all patients and would increase the generalizability of clinical trial results across all income levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
Hutchins, L. F., Unger, J. M., Crowley, J. J., Coltman, C. A., & Albain, K. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412706 · Cited by 2,174
Self-citationParticipation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities
Murthy, V. H., Krumholz, H. M., & Gross, C. P. (2004) · JAMA · doi:10.1001/jama.291.22.2720 · Cited by 2,078
Krosnick, J. A. (1999) · Annual Review of Psychology · doi:10.1146/annurev.psych.50.1.537 · Cited by 1,852
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review
Ford, J. G., Howerton, M. W., Lai, G. Y., Gary, T. L., Bolen, S., Gibbons, M. C., Tilburt, J., Baffi, C., Tanpitukpongse, T. P., Wilson, R. F., et al. (2008) · Cancer · doi:10.1002/cncr.23157 · Cited by 1,083
Can Comorbidity Be Measured By Questionnaire Rather than Medical Record Review?
KATZ, J. N., CHANG, L. C., SANGHA, O., FOSSEL, A. H., & BATES, D. W. (1996) · Medical Care · doi:10.1097/00005650-199601000-00006 · Cited by 1,035
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
Lewis, J. H., Kilgore, M. L., Goldman, D. P., Trimble, E. L., Kaplan, R., Montello, M. J., Housman, M. G., & Escarce, J. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.010 · Cited by 1,031
Barriers to Participation in Randomised Controlled Trials
Ross, S., Grant, A., Counsell, C., Gillespie, W., Russell, I., & Prescott, R. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00141-9 · Cited by 907
Talarico, L., Chen, G., & Pazdur, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.175 · Cited by 727
Lara, P. N., Higdon, R., Lim, N., Kwan, K., Tanaka, M., Lau, D. H. M., Wun, T., Welborn, J., Meyers, F. J., Christensen, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1728 · Cited by 588
Sateren, W. B., Trimble, E. L., Abrams, J., Brawley, O., Breen, N., Ford, L., McCabe, M., Kaplan, R., Smith, M., Ungerleider, R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.056 · Cited by 535
A Decade of Direct-to-Consumer Advertising of Prescription Drugs
Donohue, J. M., Cevasco, M., & Rosenthal, M. B. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa070502 · Cited by 512
Barriers to Clinical Trial Participation by Older Women With Breast Cancer
Kemeny, M. M., Peterson, B. L., Kornblith, A. B., Muss, H. B., Wheeler, J., Levine, E., Bartlett, N., Fleming, G., & Cohen, H. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.124 · Cited by 465
Public Attitudes Toward Participation in Cancer Clinical Trials
Comis, R. L., Miller, J. D., Aldigé, C. R., Krebs, L., & Stoval, E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.105 · Cited by 393
Representation of older patients in cancer treatment trials
Trimble, E. L., Cain, D., Ungerleider, R. S., Friedman, M. A., Carter, C. L., & Freidlin, B. (1994) · Cancer · doi:10.1002/1097-0142(19941001)74:7+<2208::aid-cncr2820741737>3.0.co;2-# · Cited by 343
Baquet, C. R., Commiskey, P., Daniel Mullins, C., & Mishra, S. I. (2006) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2005.12.001 · Cited by 289
Tejeda, H. A., Green, S. B., Trimble, E. L., Ford, L., High, J. L., Ungerleider, R. S., Friedman, M. A., & Brawley, O. W. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.12.812 · Cited by 269
'Due' and 'Undue' Inducements: On Pasing Money to Research Subjects
Macklin, R. (1981) · IRB: Ethics and Human Research · doi:10.2307/3564136 · Cited by 187
Gross, C. P., Filardo, G., Mayne, S. T., & Krumholz, H. M. (2005) · Cancer · doi:10.1002/cncr.20792 · Cited by 172
Paying People to Participate in Research: Why not?
McNeill, P. (1997) · Bioethics · doi:10.1111/1467-8519.00079 · Cited by 164
Willingness to Participate in Clinical Treatment Research Among Older African Americans and Whites
Brown, D. R., & Topcu, M. (2003) · The Gerontologist · doi:10.1093/geront/43.1.62 · Cited by 161
Wilkinson, M., & Moore, A. (1997) · Bioethics · doi:10.1111/1467-8519.00078 · Cited by 156
Factors Associated With Participation in Breast Cancer Treatment Clinical Trials
Avis, N. E., Smith, K. W., Link, C. L., Hortobágyi, G. N., & Rivera, E. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8976 · Cited by 143
Is Patient Travel Distance Associated With Survival on Phase II Clinical Trials in Oncology?
Lamont, E. B., Hayreh, D., Pickett, K. E., Dignam, J. J., List, M. A., Stenson, K. M., Haraf, D. J., Brockstein, B., Sellergren, S. A., & Vokes, E. E. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg035 · Cited by 139
Lara, P. N., Paterniti, D. A., Chiechi, C., Turrell, C., Morain, C., Horan, N. M., Montell, L., Gonzalez, J., Davis, S. W., Umutyan, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.6245 · Cited by 135
Hunter, C. P., Rw, F., Ar, F., Bavier, A. R., Wh, D., Ford, L., Henson, D. E., Macfarlane, D. K., Cr, S., & Yancik, R. (1987) · PubMed · Cited by 129
Re: Is Patient Travel Distance Associated With Survival on Phase II Clinical Trials in Oncology?
Munoz, A., & Samet, J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh065 · Cited by 112
Javid, S. H., Unger, J. M., Gralow, J. R., Moinpour, C. M., Wozniak, A. J., Goodwin, J. W., Lara, P. N., Williams-Piehota, P. A., Hutchins, L. F., Gotay, C. C., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0384 · Cited by 108
Self-citationImpact of the Year 2000 Medicare Policy Change on Older Patient Enrollment to Cancer Clinical Trials
Unger, J. M., Coltman, C. A., Crowley, J. J., Hutchins, L. F., Martino, S., Livingston, R. B., Macdonald, J. S., Blanke, C. D., Gandara, D. R., Crawford, E. D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8928 · Cited by 105
Self-citationFactors Influencing Enrollment in Clinical Trials for Cancer Treatment
Klabunde, C. N., Bethesda, Springer, B. C., BUTLER, B., Winston-Salem, WHITE, M. S., Raleigh, & Atkins, J. (1999) · Southern Medical Journal · doi:10.1097/00007611-199912000-00011 · Cited by 99
Impact of the Cost of Cancer Treatment: An Internet-Based Survey
Markman, M., & Luce, R. (2010) · Journal of Oncology Practice · doi:10.1200/jop.091074 · Cited by 97
Cost of Care for Patients in Cancer Clinical Trials
FIREMAN, B. H., Fehrenbacher, L., Gruskin, E. P., & Ray, G. T. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.136 · Cited by 85
Incremental Costs of Enrolling Cancer Patients in Clinical Trials: a Population-Based Study
Wagner, J. L. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.10.847 · Cited by 84
Incremental Treatment Costs in National Cancer Institute–Sponsored Clinical Trials
Goldman, D. P., Berry, S. H., McCabe, M. S., Kilgore, M. L., Potosky, A. L., Schoenbaum, M., Schonlau, M., Weeks, J. C., Kaplan, R., & Escarce, J. J. (2003) · JAMA · doi:10.1001/jama.289.22.2970 · Cited by 77
Bergman, L., Dekker, G., van Kerkhoff, E. H., Peterse, H. L., van Dongen, J. A., & van Leeuwen, F. E. (1991) · Breast Cancer Research and Treatment · doi:10.1007/bf01990035 · Cited by 77
Jacobsen, P. B., Wells, K. J., Meade, C. D., Quinn, G. P., Lee, J., Fulp, W. J., Gray, J. E., Baz, R., Springett, G. M., Levine, R. M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5186 · Cited by 67
Efforts to recruit the economically disadvantaged to national clinical trials
McCabe, M. S., Varricchio, C. G., & Padberg, R. M. (1994) · Seminars in Oncology Nursing · doi:10.1016/s0749-2081(05)80066-x · Cited by 66
Clinical trial participation among patients enrolled in the Glioma Outcomes Project
Chang, S. M., Barker, F. G., Schmidt, M. H., Sloan, A. E., Kasper, R. S., Phillips, L. E., Shih, K. M., Hariharan, S., Berger, M. S., & The Glioma Outcomes Investigators (2002) · Cancer · doi:10.1002/cncr.10536 · Cited by 54
Socio-Economic Status and Inducement to Participate
Viens, A. M. (2001) · The American Journal of Bioethics · doi:10.1162/152651601300169202 · Cited by 25
Drug costs and out-of-pocket spending in cancer clinical trials
Kilgore, M. L., & Goldman, D. P. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2007.04.004 · Cited by 12
Cited by
The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies
Unger, J. M., Cook, E., Tai, E., & Bleyer, A. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_156686 · Cited by 665
Self-citationDifferences in Breast Cancer Survival by Molecular Subtypes in the United States
Howlader, N., Cronin, K. A., Kurian, A. W., & Andridge, R. (2018) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0627 · Cited by 598
Loree, J. M., Anand, S., Dasari, A., Unger, J. M., Gothwal, A., Ellis, L. M., Varadhachary, G., Kopetz, S., Overman, M. J., & Raghav, K. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.1870 · Cited by 570
Self-citationUnger, J. M., Vaidya, R., Hershman, D. L., Minasian, L. M., & Fleury, M. E. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy221 · Cited by 570
Self-citationBooth, C. M., & Tannock, I. F. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.725 · Cited by 469
Metadata
- Authors
- Unger, J. M., Hershman, D. L., Albain, K. S., Moinpour, C. M., Petersen, J. A., Burg, K., & Crowley, J. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2013-02-10
- Volume
- 31
- Issue
- 5
- Pages
- 536-542
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2064370814
- Cited by
- 290
- References
- 39
- FWCI
- 15.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.